Bill117th CongressFiled Mar 9, 2022Health
H.R. 7032
Increasing Transparency in Generic Drug Applications Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 9, 2022)
Increasing Transparency in Generic Drug Applications Act of 2022
This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
What just happenedMar 10, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Kuster, Ann M. [D-NH-2](D-NH)Sponsor
1 cosponsor1 D
1cosponsors1committees4actions2related bills4subjects
- Introduced in HouseMar 9, 2022
- Mar 10, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 9, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 9, 2022IntroReferralIntro-H
Introduced in House
- Mar 9, 2022IntroReferral1000
Introduced in House